Cresp 40mcg Injection (PFS) contains Darbepoetin alfa, a medicine from the class of erythropoiesis stimulating agents. It is used to treat symptomatic anemia caused by chronic kidney disease (CKD) in both adults and children. In CKD, kidneys produce less erythropoietin a hormone needed to make red blood cells leading to anemia.
Before starting treatment, your doctor will likely perform blood tests to monitor your response and may adjust your dose accordingly. Blood pressure will also be closely monitored, especially during the early stages of treatment.
This injection is not recommended for patients with uncontrolled high blood pressure. Inform your doctor if you have a history of controlled hypertension, sickle cell anemia, seizures, liver disease, poor response to previous anemia treatments, latex allergy, or hepatitis C.
Use of Cresp 40mcg Injection should be done with caution in pregnant women, and breastfeeding is not advised during treatment. It is not recommended for infants under 1 month old with CKD. Its safety and effectiveness in children with cancer have not been established, so always consult a pediatrician for guidance.
Common side effects may include increased blood pressure, allergic reactions, pain at the injection site, skin rash, or redness. Contact your doctor if any side effects become severe or persistent.
Cresp 40mcg Injection is used to treat symptomatic anemia (low red blood cell count) in patients with chronic renal failure, including those on dialysis and those not on dialysis. It helps stimulate the bone marrow to produce more red blood cells by mimicking the action of erythropoietin, a natural hormone usually produced by healthy kidneys.
It is also indicated for use in children with CKD who are experiencing anemia, helping to reduce symptoms such as fatigue, weakness, and shortness of breath.
Cresp 40mcg Injection contains Darbepoetin alfa, a synthetic form of erythropoietin, a hormone naturally produced by the kidneys. It works by stimulating the bone marrow to produce more red blood cells.
In patients with chronic kidney disease (CKD), the kidneys fail to produce enough erythropoietin, leading to anemia. Darbepoetin alfa binds to the erythropoietin receptors on bone marrow cells, activating them to increase red blood cell production. This helps improve oxygen delivery throughout the body and relieves symptoms of anemia such as tiredness and weakness.
Side Effects of Cresp 40mcg Injection
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
The dosage of Cresp 40mcg Injection (Darbepoetin alfa) depends on the patient's body weight, the severity of anemia, and whether the patient is on dialysis or not. It is usually administered under the supervision of a healthcare professional.
Note: Cresp Injection should always be used exactly as prescribed. Never self administer or change the dose without consulting your doctor.
Do not breastfeed while receiving Cresp, as it is not known if the medicine passes into breast milk and may affect your baby.
There is no known interaction with alcohol, but it’s best to consult your doctor before consuming alcohol while using this medicine.
Cresp Injection may rarely cause breathing issues or lung problems. Seek medical help if you develop chest pain, cough, or shortness of breath, and inform your doctor about any existing lung conditions.
Cresp is not likely to affect your ability to drive or use machines. However, if you feel dizzy, tired, or unwell, avoid driving until you feel better.
Cresp should be used during pregnancy only if clearly needed. Talk to your doctor about the risks and benefits before starting this medication.
Cresp 40 mcg Injection is used to treat anemia caused by chronic kidney disease (CKD) in both adults and children. It helps your body make more red blood cells.
It contains Darbepoetin alfa, which acts like a natural hormone called erythropoietin. It stimulates the bone marrow to produce red blood cells, helping to improve symptoms like tiredness and weakness.
It is given either under the skin (subcutaneous) or into a vein (intravenous), usually by a doctor or nurse at a hospital or clinic.
The frequency depends on your condition. It is usually given once a week, every two weeks, or even every four weeks, based on your response and whether you are on dialysis.
In some cases, your doctor may train you or a caregiver to give the injection at home. Always follow medical guidance carefully if doing so.
Common side effects include high blood pressure, injection site pain, rash, and flu-like symptoms. Serious side effects like seizures or allergic reactions are rare but require immediate medical attention.
Cresp should be used in pregnancy only if advised by your doctor. Do not breastfeed while using this medicine.
Yes, it can be used in children with anemia caused by kidney disease, but not in infants under 1 month of age. Safety in children with cancer has not been established.
If you miss a dose, inform your doctor as soon as possible. Do not double the dose to make up for the missed one.
No. Do not stop the treatment without consulting your doctor, even if you feel better. Stopping it suddenly may cause your anemia to return.
| Active ingredient | Darbepoetin alfa |
| Pharmacologic class | Erythropoiesis-Stimulating Agent (ESA) |
| Medication category | Hematopoietic Agent |
| Dosage forms | Injection |
The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.
Life-Saving Medicines Expert
Affordable Patient-Centered Care
Authentic, Top-Quality Medicines
Careful & Timely Medicine Deliveries
Login with Facebook
Login with Google
